CytoMed Therapeutics Limited Ordinary Shares

GDTCNASDAQ • USD
0.79 USD
↗ 0.01 (1.43%)🟢LIVE (AS OF 11:49 AM EST)
🟢Market: OPEN

CytoMed Therapeutics Limited Ordinary Shares (GDTC) is currently trading at $0.79. Technical indicators currently signal "Strong Sell". This is driven by a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Nov 16, 2026.

Open?$0.76
High?$0.79
Low?$0.75
Prev. Close?$0.77
Volume?6.5K
Avg. Volume?N/A
VWAP?$0.78
Bid / Ask
Bid?$0.65 × 100
Ask?$0.97 × 100
Spread?$0.32
Midpoint?$0.81
Valuation & Ratios
Market Cap?9.9M
Shares Out?11.8M
Float?4.3M
Float %?36.6%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
Employees
42
Market Cap
9.9M
Industry
N/A
Listed
2023-04-14
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.41%Low
Short Interest?17.6K
Days to Cover?1.8
Free Float4.3M
Avg Daily Volume9.7K
Settlement Date2026-10-30